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Purpose: To determine the in vitro accuracy, test-retest
repeatability, and interplatform reproducibility of T1 quantifica-
tion protocols used for dynamic contrast-enhanced MRI at 1.5
and 3 T.
Methods: A T1 phantom with 14 samples was imaged at eight
centers with a common inversion-recovery spin-echo (IR-SE)
protocol and a variable flip angle (VFA) protocol using seven
flip angles, as well as site-specific protocols (VFA with different
flip angles, variable repetition time, proton density, and Look-
Locker inversion recovery). Factors influencing the accuracy
(deviation from reference NMR T1 measurements) and repeat-
ability were assessed using general linear mixed models. Inter-
platform reproducibility was assessed using coefficients of
variation.
Results: For the common IR-SE protocol, accuracy (median
error across platforms¼1.4–5.5%) was influenced predomi-
nantly by T1 sample (P<10
6), whereas test-retest repeatabil-
ity (median error¼0.2–8.3%) was influenced by the scanner
(P<106). For the common VFA protocol, accuracy (median
error¼5.7–32.2%) was influenced by field strength (P¼0.006),
whereas repeatability (median error¼0.7–25.8%) was influ-
enced by the scanner (P<0.0001). Interplatform reproducibility
with the common VFA was lower at 3 T than 1.5 T (P¼0.004),
and lower than that of the common IR-SE protocol (coefficient
of variation 1.5T: VFA/IR-SE¼11.13%/8.21%, P¼0.028; 3 T:
VFA/IR-SE¼22.87%/5.46%, P¼0.001). Among the site-
specific protocols, Look-Locker inversion recovery and VFA
(2–3 flip angles) protocols showed the best accuracy and
repeatability (errors<15%).
Conclusions: The VFA protocols with 2 to 3 flip angles opti-
mized for different applications achieved acceptable balance
of extensive spatial coverage, accuracy, and repeatability in T1
quantification (errors<15%). Further optimization in terms of
flip-angle choice for each tissue application, and the use of B1
correction, are needed to improve the robustness of VFA pro-
tocols for T1 mapping. Magn Reson Med 79:2564–2575,
2018. VC 2017 International Society for Magnetic Resonance
in Medicine.
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INTRODUCTION
Dynamic contrast-enhanced MRI (DCE-MRI) is often
used to quantify flow and permeability in various tumors
(1–3) and organs (brain, breast, liver, kidney, prostate)
(4–10). Dynamic contrast-enhanced MRI captures the sig-
nal change in time with the intravenous injection of a
gadolinium-based contrast agent by acquiring T1-
weighted images before, during, and after injection of
contrast agent at a high temporal resolution. The signal-
time curves are usually converted to gadolinium
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concentration-time curves (5), reflecting the contrast
agent uptake and washout of the tissue of interest. Phar-
macokinetic modeling (11–13) can then be applied to the
concentration-time curves to determine tissue biological
parameters such as intravascular-extravascular transfer
rate constant for the contrast agent, Ktrans, and extravas-
cular and extracellular volume fraction, ve. The precision
of pharmacokinetic parameters is highly dependent on
the conversion of T1-weighted signal to gadolinium con-
centration, and thus on the precontrast (native) T1 value
of the tissue of interest (8,14).
A simple approach is to assign a published T1 value to
the tissue of interest (15–17). However, because
literature-derived T1 values are often based on studies in
healthy volunteers (18), this approach does not account
for changes in tissue T1 that occur with age (8) or disease
(19,20). Further limitations of using a constant,
literature-based baseline T1 are that it does not account
for interpatient variability and cellular heterogeneity in
the tissue of interest (11,19,20). The need for patient and
tissue-specific DCE-MRI parameters motivates the effort
to develop accurate, widely available precontrast T1
measurements.
The longitudinal relaxation time T1 can be measured
by a variety of methods (21,22). The multiple-delay
inversion-recovery (IR) method that originated from his-
torical NMR experiments (23,24) is considered the refer-
ence standard, but has limited spatial coverage and long
acquisition times, which makes it impractical in clinical
settings. The Look-Locker modified IR method (25–27)
decreases the acquisition time by sampling the signal
recovery curve multiple times per repetition time (TR)
after application of several low flip-angle pulses during
the acquisition. Despite shortened acquisition time,
Look-Locker IR methods are still limited in spatial cover-
age. Another method that shares some of the same limi-
tations as the IR method but with shorter overall scan
times is the variable TR (VTR) method, in which T1-
weighted signal is acquired with multiple TR values (8).
A frequently used alternative approach is to vary the
radiofrequency tip angle while keeping the TR constant
in a 3D spoiled gradient-echo acquisition, as in variable
flip angle (VFA) methods (8,22,28,29). Variable flip angle
measurements allow for voxel-based baseline (pre-DCE-
MRI) T1 mapping with the same spatial resolution and
coverage as the DCE-MRI scan in a short amount of time.
Similarly time-efficient, although less popular, is the
proton density (PD) approach (30), in which T1 is
derived by comparing PD-weighted images with DCE
baseline (precontrast) images.
Previous publications have reported interscanner and
intersite variability in the T1 values measured with dif-
ferent methods (31,32), including the IR method (22). In
the brain, the Look-Locker modified IR method was
found to consistently underestimate, and the VFA
method to consistently overestimate, T1 values in the
white matter (22). The accuracy and test-retest repeat-
ability of measured T1 values are influenced by the same
factors that affect the generation and acquisition of MR
signal, such as temperature in the magnet bore (32),
incomplete spoiling of transverse magnetization (33) and
B1 field inhomogeneity (8,22), the choice of the optimal
sequence, and sequence parameters for the range of T1
values to be measured. Additional factors contributing to
variability include postprocessing, such as signal scaling
by the image processing software (34) and the assump-
tions for the fitting function (22).
This study seeks to identify and systematically investi-
gate some of the sources of variability in the T1 measure-
ment process using a dedicated phantom in a
multicenter setting. The described research was con-
ducted by the Data Acquisition Working Group of the
National Cancer Institute–sponsored Quantitative Imag-
ing Network (35,36), whose purpose is to improve the
repeatability and reproducibility of quantitative imaging,
and promote its adoption as an evaluation tool in oncol-
ogy clinical trials.
The purpose of our study was to determine the (i)
accuracy (with respect to reference standard NMR T1 val-
ues) of T1 measurements obtained with two predefined
T1 measurement protocols common among participating
sites, and with the specific T1 measurement protocol(s)
used at each participating site for DCE-MRI studies; (ii)
test-retest repeatability of T1 measurements obtained
with the common and site-specific T1 measurement pro-
tocol(s); and (iii) Interplatform reproducibility of the
common T1 mapping protocols at 1.5 and 3T.
METHODS
A preliminary survey identified eight Quantitative Imag-
ing Network sites that measured the baseline-tissue T1
for DCE-MRI quantification, rather than using a fixed T1
based on the literature. The DCE-MRI with T1 measure-
ment is performed at 1.5 T (two sites, two scanners) and
3T (seven sites, eight scanners), for different organs or
neoplasms (Table 1). The methods and protocols used
for T1 measurement varied among sites, with VFA meth-
ods being the most common (Table 1) because of the
achievable extensive spatial coverage in a short amount
of time.
National Institute of Standards and Technology T1
Phantom and NMR Reference T1 Measurement
To assess accuracy, repeatability and reproducibility of
T1 measurements among platforms, sequences, and pro-
tocols, we used a phantom containing the T1 elements
(Fig. 1) from the National Institute of Standards and
Technology (NIST) system phantom (31,32,37). The
phantom consists of a 192-mm outer-diameter polycar-
bonate sphere filled with deionized water, containing a
plastic plate with positioning markers and T1 solution
array. The T1 array consists of 14 polycarbonate spheres
(15-mm inner diameter, 20-mm outer diameter each),
with 10 spherical samples equally spaced on a 50-mm
diameter circle, and four inside the circle on a 40-mm
grid. The anatomical directions on the central plate facil-
itate positioning of the phantom at scanner isocenter,
with the central plate parallel to the coronal plane of the
scanner. T1 values in the range of 20 to 2000 ms were
obtained by doping deionized water with NiCl2. The
NiCl2 concentrations of the solutions used to create the
samples were determined by traceable inductively cou-
pled plasma mass spectrometry measurements. The
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solutions are well-characterized and monitored by NIST
for stability and accuracy (37).
The NMR spectroscopy reference measurements were
performed at 1.5 and 3T by NIST investigators. Aliquots
of each of the 14 NiCl2 solutions were sealed into 2-mm
outer-diameter quartz NMR tubes, which were then
flame-sealed using a methane/oxygen torch. A fiber-optic
temperature probe was positioned with the sensor in the
middle of the radiofrequency coil. Each sample was
equilibrated to 293.15 K (20C) for a minimum of 15min.
Samples were shimmed using the Berger-Braun shim-
ming method before collecting NMR-IR relaxation-time
data (24).
Image Acquisition
The Working Group developed a uniform T1 phantom
imaging protocol in collaboration with NIST. The T1
phantom, along with a digital thermometer and scanning
instructions, was shipped to the eight Quantitative Imag-
ing Network centers, where it was scanned in duplicate
(test-retest) sessions. The phantom was placed in the
scanner room 8h before scanning, to allow its tempera-
ture to stabilize. Temperature was measured in the bulk
water of the phantom at the start and end of each experi-
ment, with the provided digital thermometer. Sites were
instructed to image the phantom using the same receive
coils (head or body array) used for their DCE-MRI stud-
ies. Sites (5 and 8) performing breast DCE-MRI studies
used head coils, as the phantom was too large to fit into
breast coils. The phantom was positioned with the aid of
a level to ensure that the T1 array plate was aligned with
the principal scanner directions (superior–inferior, ante-
rior–posterior), and that the central NIST marker was
located at scanner isocenter.
The phantom was scanned on 10 different platforms
(Table 1) at two field strengths (two at 1.5T and eight at
3T) from three major vendors (Siemens Healthineers
(Erlangen, Germany), GE Healthcare (Waukesha, WI),
and Philips Healthcare (Best, the Netherlands)). All sites
collected data with a common inversion-recovery spin-
echo (IR-SE) protocol and a common VFA protocol with
seven flip angles. Both protocols were optimized to mea-
sure the full T1 range of the NIST phantom (20–2000
ms). A VFA sequence was chosen to build a common
scanning protocol, as the VFA method was used by most
sites (Table 1) for T1 quantification in DCE-MRI. The
scanning parameters of the common protocols, matched
closely among the platforms, are summarized in Table 2.
Additionally, seven of the eight sites collected data
using the site-specific T1 measurement protocols. The
organs of interest for DCE-MRI studies, the T1 mapping
method, and scanner(s) on which the data were acquired
at each site are summarized in Table 1. The 14 site-
Table 1
Overview of Sites, Organs of Interest, Scanner Systems, and Site-Specific T1 Mapping Protocols
Site Organ Scanner No. Scanner Site-Specific Protocols
1 Prostate 1 GE Discovery w750 (3 T) VTR
2 Brain 2 Siemens Skyra (3 T) VFA
3 Tim Trio (3 T)
3 Liver, prostate 4 Siemens Skyra (3 T) VFA, Look-Locker
9 Siemens Aera (1.5 T)
4 Soft tissue sarcoma 5 Siemens Tim Trio (3 T) PD
5 Breast 10 GE HDx (1.5 T) VFA
6 Brain 6 Philips Ingenia (3 T) VTR
7 Brain 7 Siemens Skyra (3 T) VFA
8 Breast 8 Philips Achieva (3 T) VFA
Note: Sites are listed in random order; scanners are ordered by decreasing field strength (3 T: scanners 1–8; 1.5 T: scanners 9 and 10)
and by site number.
FIG. 1. (left) View of the NIST T1 phantom from the top. Phantom positioning mimics the positioning of a patient lying head-first, supine
on the MRI table (eye decals facing up, toward the scanner bore), so that the central plate is parallel to the coronal imaging plane. (cen-
ter) View of the T1 phantom from the side. (right) Central plate of the NIST T1 phantom demonstrating positioning of the 14 samples
(S1–S14) of NiCl2 solution, with T1 ranging from 22 to 2033 ms in descending order, determined by NMR spectroscopy at 1.5 and 3 T
(Supporting Table S3).
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specific T1 measurement protocols, their associated
acquisition parameters, as well as the range of T1 values
they were optimized to measure, are summarized in
order of scanner number in Supporting Tables S1 and
S2. Briefly, site-specific protocols included four meth-
ods: (i) VFA (nine protocols: protocols 2 and 3 for brain;
4b and 9b for liver; 4c, 9c, and 9d for prostate; and 8 and
10 for breast), (ii) VTR (two protocols: protocol 1 for
prostate; 6 for brain); (iii) Look-Locker modified IR (two
protocols: 4a and 9a for liver); and (iv) PD (one protocol:
protocol 5 for soft-tissue sarcoma). The site-specific VFA
protocols had 2 to 10 flip angles, and choice of flip
angles was optimized for the anatomical application.
Image Analysis
Centralized data analysis was performed at one site
(Icahn School of Medicine at Mount Sinai, New York,
NY). The acquired T1 data were uploaded by participat-
ing sites in DICOM format. Data were analyzed by a sin-
gle observer (O.B., a physicist with 4 years of
postdoctoral experience in image analysis), who placed
circular regions of interest (average size 1.0 cm2) in a
central slice of each sphere using OsiriX Lite (version
8.0.2, Pixmeo SARL, Bernex, Switzerland). For Philips
scanners, the signal intensity (SI) values (arbitrary units)
were modified by scaling factors and stored in “private”
DICOM fields by the vendor (38), converted to floating
point values (34), and then used for calculations. The
mean region-of-interest SI was fitted according to the sig-
nal equation for each sequence (Supporting Information
Eqs. [1]–[5]) to obtain T1 values, using custom routines
written in MATLAB R2015 (The MathWorks, Natick,
MA).
Statistical Analysis
Statistical analysis was performed using MATLAB R2015
and SAS 9.4 (SAS Institute, Cary, NC). Statistical signifi-
cance was defined as P< 0.05. Agreement of IR-SE T1
measurements with reference NMR T1 measurements
was tested by Lin’s concordance correlation coefficient
(39,40) and Bland-Altman statistics.
Accuracy was assessed with respect to NMR T1 values
as the reference. The accuracy error was computed as
the percentage difference between T1 measured with the
common or site-specific protocols during the first (test)
scanning session, and reference NMR T1 (Eq. [1]).
Smaller values represent higher accuracy.
Accuracy Error ð%Þ ¼ 100  jT1 protocol  T1 NMRj=T1 NMR
[1]
Test-retest repeatability was assessed by the precision
error, calculated as the percentage difference of T1 values
measured in duplicate relative to the mean of the two
measured values (Eq. [2]). Smaller values represent
higher repeatability.
Precision Error ð%Þ ¼ 100  jT1 test  T1 retestj
=Mean ðT1 test; T1 retestÞ [2]
A general linear mixed model was used to compare the
accuracy and precision errors of T1 measurements across
samples, field strengths, scanners, vendors, methods,
and protocols (26). The effects of sample (solution), field,
scanner (individual platform), and vendor on the accu-
racy and precision errors of the common IR-SE and VFA
protocol were tested separately and in combination. For
site-specific protocols data, the acquisition protocol and
measurement method were tested as additional predic-
tive variables. The “protocol” variable represented each
site-specific combination of sequence implementation
and acquisition parameters (14 site-specific protocols
listed in Supporting Tables S1 and S2), whereas the
“method” variable encoded each of the four T1 measure-
ment methods (VFA, Look-Locker modified IR, VTR, and
PD) used to generate data submitted by the sites.
A stepwise model selection procedure was performed
(41,42) to identify the best subset of one or more inde-
pendent, uncorrelated predictors of accuracy or preci-
sion. Model results were reported as least-square
means6 standard error, with smaller numbers represent-
ing better accuracy or precision. Comparisons of accu-
racy and precision errors were performed among the
following factors: samples, field strengths, scanners, ven-
dors, protocols (in the case of site-specific protocols for
different anatomical applications), and methods (for site-
specific protocol data). Type 3 P values were reported
for the general linear mixed model (43), and Tukey
adjusted P values (44) were reported for comparisons
between factors.
Interplatform reproducibility for the T1 measured in
each sample with the common IR-SE and VFA protocols
was assessed by intraclass correlation coefficient (ICC)
and coefficient of variation (% CV¼ 100 x standard devi-
ation/mean calculated between platforms, for each refer-
ence T1 value). Paired sample Wilcoxon signed-rank
tests were used to compare CVs between field strengths
and common protocols.
RESULTS
T1 measurements were obtained on 10 scanners at two
field strengths (1.5T: two scanners; 3T: eight scanners),
Table 2
Standardized Acquisition Parameters of IR-SE and VFA Methods,
Used to Image the NIST T1 Phantom at All Sites
IR-SE VFA
Orientation Coronal Coronal
Flip angle () 180 2, 5, 10, 15, 20,
25, 30
Echo time (ms) 9 2
Repetition time (ms) 5000 12
Inversion time (ms) 24, 50, 75, 100, 125,
150, 250, 500, 750,
1000, 2000, 3000
—
Field of view (mm2) 200 3 200 200 3 200
Number of slices 1 16
Slice thickness (mm) 5–6 5–6
Matrix 256 3 256 256 3 256
Echo train length 5–6 —
Number of averages 1 3
Acquisition time (min) 45 13
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in duplicate sessions, with two common protocols and
14 site-specific protocols. All sites were able to imple-
ment the common protocols, with two minor exceptions
(lowest TI¼50 ms for the common IR-SE on the GE
scanners 1 and 10, instead of 24 ms, and FA¼19 
instead of 20  for the common VFA protocol at site 4, on
scanner 5, a Siemens Trio machine). Fourteen phantom
samples were analyzed for the scans with the common
protocols, totaling 560 (14  10  2  2) T1 measure-
ments. Only the samples with T1 values within the mea-
surement range for which the site-specific protocols
were optimized (8,19,20,28,30,45). T1 ranges for each
anatomical application, given in Supporting Tables S1
and S2, were analyzed, totaling 112 (56  2) T1 measure-
ments with the site-specific protocols. Goodness of fit
was assessed by the coefficient of determination (R2),
which ranged between 0.85 and 0.99 for T1 measurement
with the common IR-SE protocol, between 0.88 and 0.99
for measurements with the common VFA protocol, and
between 0.82 and 0.99 for measurements with site-
specific protocols. Typical fit plots for the common pro-
tocols are shown in Supporting Figures S2 and S3.
Temperature measurements in the bulk water of the
phantom ranged between 18.5 and 22.6 C at the start
(mean 20.861.15 C), and between 19.6 and 22.7 C at
the end (mean 21.361.1 C) of experiments, with a tem-
perature change observed between the start and end of
experiments of 0.46 0.4 C.
Comparison of IR-SE and NMR Reference Measurements
The NMR reference measurements are listed in Supporting
Table S3 for each solution sample. There was excellent
concordance between IR-SE and NMR measurements (con-
cordance correlation coefficient> 0.99; P< 106), with
some deviations from unity line observed at T1¼ 500 ms
and T1> 1500 ms (Fig. 2a). Bland-Altman plots for all
scanners (Fig. 2b) show near-zero bias, limits of agreement
(230%, 30%), and highlight discrepancies between IR-SE
and NMR T1 at reference T1¼ 50 ms (scanners 2–9) and
T1¼ 500 ms (scanners 1 and 10), with these values outside
the limits of agreement. The deviation at 500 ms is caused
by underperformance of fit (Supporting Information Eq.
[1]) in some data sets (scanners 1, 6, 8, and 10) (Supporting
Fig. S1). When used without lower and upper bounds for
the parameters, the fit performs better in some cases (Sup-
porting Fig. S1), but in other cases returns nonphysical fit-
ted parameters (e.g., negative noise, 1-cos (Inversion
Angle)> 2). Because of these deviations, only the NMR
measurements were used as the reference standard for the
calculation of accuracy.
Accuracy Assessment
Common IR-SE Protocol
The results of the accuracy assessment of the common
IR-SE protocol are displayed in Table 3 and Figure 3.
For the full range of reference T1 values of the phantom
solutions (20–2000 ms), the range of median accuracy
error among the 10 platforms (Table 3) was 1.4 to 5.5%.
The distributions of accuracy errors for ranges of
low (40–100 ms), intermediate (100–500 ms), and high
(500–2000 ms) T1 values are summarized in Supporting
Table S4. Among the factors tested separately in a gen-
eral linear mixed model, the sample (solution), or the
actual T1 value, was identified as a significant (P<10
6)
independent predictor of accuracy (Fig. 3) for T1 meas-
urements with the common IR-SE protocol. T1 measure-
ments were significantly less accurate for solution
sample S12 (reference T1 45 ms) than for all other sam-
ples (Fig. 3; adjusted P< 106).
Common VFA Protocol
For the full range of reference T1 values of the phantom
solutions (20–2000 ms), the range of median accuracy
error among the 10 platforms (Table 3) was 5.7 to 32.2%.
The distributions of accuracy errors for ranges of low
(40–100 ms), intermediate (100–500 ms), and high (500–
2000 ms) T1 values are summarized in Supporting Table
S4. Field strength was identified as a significant
(P¼ 0.006) independent predictor (Fig. 3), and scanner
(Fig 3; P¼ 0.0003) as a significant predictor of accuracy
of T1 measurements with the common VFA protocol.
T1 measurements with the common VFA protocol
were overall less accurate (adjusted P¼ 0.006) at 3T than
at 1.5 T (Fig. 3). However, of the eight 3T scanners, seven
scanners did not reach a statistically different accuracy
error than the two 1.5T scanners (Fig. 3). Significant dif-
ferences in accuracy of the common VFA protocol among
scanners are summarized in the Supporting Information.
Site-Specific Protocols
The results of the accuracy assessment of the site-specific
protocols are shown in Figure 4. Accuracy errors ranged
between 3.2 and 37.2% for the site-specific protocols. The
VTR protocol 1 for the prostate, Look-Locker protocol 4a
for the liver, VFA protocol 4b for the liver, VFA protocol
9b for the liver, and VFA 9c and 9d for the prostate had
accuracy errors of less than 15%. Protocol (P¼ 0.002) and
scanner (P¼0.0014) were identified as significant predic-
tors of accuracy of T1 measurements with the site-specific
protocols. The stepwise model-selection procedure identi-
fied no independent predictors of accuracy.
The VTR protocol 1 for the prostate was significantly
more accurate (adjusted P¼ 0.03) than protocol 2 (VFA
for brain at 3T with six flip angles; Supporting Table
S2). Among VFA protocols (2, 3, 4b, 4c, 8, 9b, 9c, 9d;
Supporting Tables S1 and S2), protocols 9c and 9d for
the prostate (VFA with two flip angles at 1.5T; Support-
ing Table S2) were significantly (adjusted P¼ 0.03) more
accurate than protocol 2.
Test-Retest Repeatability Assessment
Common IR-SE Protocol
The median precision error range across scanners was
0.2 to 8.3% for the full range of reference T1 values in
the phantom (Table 3). The distributions of precision
errors for ranges of low, intermediate, and high reference
T1 values are summarized in Supporting Table S5.
Among the factors tested, scanner was identified as a sig-
nificant (P<106) independent predictor of test-retest
repeatability for T1 measurements with the IR-SE
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common protocol (Fig. 5). The IR-SE T1 measurements
were significantly less repeatable on scanner 7 than on
all of the other scanners (Fig. 5; adjusted P<106).
Common VFA Protocol
The median precision error range across scanners was
0.7 to 25.8% for the full range of reference T1 values in
the phantom solutions (Table 3). The distributions of
precision errors for ranges of low, intermediate, and high
reference T1 values are summarized in Supporting Table
S5. Field (P<0.0001), scanner (P< 106), and vendor
(P¼ 0.0012) were identified as significant predictors of
test-retest repeatability of T1 measurements with the
common VFA protocol, when tested separately in a gen-
eral linear mixed model. The model-selection procedure
identified scanner as the independent predictor of test-
retest repeatability (Fig. 5). Among the variable subsets
FIG. 2. a: Correlation plots between IR-SE and reference NMR T1 values at 3 T (left) and 1.5 T (right). Values were highly correlated (Lin’s
concordance correlation coefficient>0.9). However, systematic deviation of IR-SE T1 values from reference NMR values was observed
at long T1. b: Bland-Altman plots showing differences (%) between IR-SE and reference NMR T1 values for all scanners. There is high
agreement between values, with bias near zero and limits of agreement (230%, 30%), with measurements at reference T1¼50 ms and
T1¼500 ms outside the limits of agreement.
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not containing scanner, field was the independent pre-
dictor of test-retest repeatability. In subsets excluding
scanner or field, vendor was the independent predictor
of test-retest repeatability. Overall, T1 measurements
were less repeatable at 3T than at 1.5T (adjusted
P< 0.0001) (Fig. 5). Similar to the accuracy results, five
of the eight 3T scanners had substantially worse perfor-
mance for repeatability of measurements than the two
1.5T scanners (Fig. 5; see also Supporting Information).
Site-Specific Protocols
The results of repeatability assessment of the site-specific
protocols are shown in Figure 4. Precision errors ranged
between 0.25 and 40% for the site-specific protocols. Look-
Locker protocols 4a and 9a for the liver, VFA protocols 2
and 3 for the brain, VFA protocol 8 for the breast, VFA
protocol 9b for the liver, and VTR protocol 6 for the brain
had precision errors of less than 15%. Complete statistical
comparison results for the repeatability of site-specific pro-
tocols are provided in the Supporting Information.
Protocol (P<0.0001), scanner (P¼ 0.0001), vendor
(P¼ 0.0001), and method (P¼0.035) were identified as
significant predictors of test-retest repeatability of T1
measurements with the site-specific protocols, when
tested separately in a general linear-mixed model. The
model-selection procedure identified protocol as an
independent predictor of repeatability.
FIG. 3. Accuracy errors of the IR-SE and VFA common protocols for each solution sample with reference T1 value (top), field strength
(middle), and scanner (bottom), using NMR measurement as the reference. The accuracy errors were calculated for the T1 measure-
ments in the test scanning session, using NMR measurements as the reference. Bar graphs represent general linear model least square
means6 standard error. Smaller numbers represent better accuracy. Sample was the significant (P<106) independent predictor of
accuracy of IR-SE T1 measurements; field was the significant (P¼0.006) independent predictor; and scanner was a significant
(P¼0.0003) predictor of accuracy of T1 measurements with the VFA common protocol.
Table 3
Accuracy and Precision Errors for Each Scanner, With the Common IR-SE and VFA Protocols, for Reference T1 Values (22.9–2033 ms at
1.5 T; 21.7–1989 ms at 3 T) in the Phantom Solution Samples
Accuracy Error (%) Precision Error (%)
Scanner
No.
Field
(T) IR-SE VFA IR-SE VFA
1 3 1.4 (3.1) 10.4 (34.0) 0.3 (0.7) 5.1 (5.7)
2 3 4.2 (5.1) 21.3 (21.5) 0.2 (0.5) 0.7 (1.4)
3 3 3.3 (5.7) 24.1 (11.7) 0.2 (0.2) 15.3 (3.5)
4 3 5.5 (7.2) 8.1 (12.4) 0.4 (0.2) 25.8 (2.3)
5 3 3.6 (7.6) 10.4 (12.7) 0.4 (0.2) 19.0 (1.2)
6 3 1.7 (3.7) 32.2 (13.6) 1.4 (1.3) 22.9 (5.8)
7 3 4.1 (6.8) 5.7 (7.2) 8.3 (12.3) 3.4 (1.5)
8 3 2.4 (4.1) 6.9 (10.0) 0.4 (0.4) 1.4 (1.3)
9 1.5 4.5 (4.0) 8.0 (5.1) 0.2 (0.2) 2.1 (1.0)
10 1.5 1.6 (2.8) 6.1 (7.8) 0.7 (0.9) 1.9 (0.9)
Note: Values are given as median (interquartile range).
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FIG. 4. Significant predictors of accuracy (left) and test-retest precision (right) errors of T1 measurements with site-specific protocols.
The accuracy errors were calculated for the T1 measurements in the test scanning session, using NMR measurements as the reference.
The precision error was calculated as the relative mean percentage difference between T1 values measured in the test and re-test scan-
ning sessions. The results of general linear mixed models are presented as least square means6 standard error. Smaller numbers repre-
sent better accuracy/ test-retest repeatability. Site-specific protocols, by scanner number, are as follows: 1, prostate VTR; 2, brain VFA
I; 3, brain VFA II; 4a, liver Look-Locker 3 T; 4b, liver VFA 3 T; 4c, prostate VFA 3 T; 5, soft-tissue sarcoma PD; 6, brain VTR; 8, breast
VFA 3 T; 9a, liver Look-Locker 1.5 T; 9b, liver VFA 1.5 T; 9c, prostate VFA I 1.5 T; 9d, prostate VFA II 1.5 T; 10, breast VFA 1.5 T. Site/scan-
ner 7 did not provide site-specific data. (left) Protocol was a significant predictor of accuracy (P¼0.002). (right) Protocol was a signifi-
cant predictor of repeatability (P<0.0001).
FIG. 5. Precision errors of the IR-SE and VFA common protocols for each solution sample with reference T1 value (top), field strength
(middle), and scanner (bottom). The precision error was calculated as the relative mean percentage difference between T1 values mea-
sured in the test and re-test scanning sessions. Bar graphs represent general linear model least square means6 standard error. Smaller
numbers represent better repeatability. Field was a significant (P<0.0001) predictor of precision errors with the common VFA protocol.
Scanner was the significant, independent predictor of precision error of T1 measurements with the common IR-SE protocol (P<10
6)
and the common VFA protocol (P<106).
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Protocols with more prescribed flip angles (protocols 2
and 3 for the brain at 3T with six and seven flip angles,
and protocol 8 for the breast at 3T with 10 flip angles)
had significantly better test-retest repeatability than VFA
protocols with two or three flip angles (protocol 4b for
the liver, 9c and 9d for the prostate; adjusted P< 104).
The VFA protocols for the same anatomical application
were more repeatable at 1.5 T than at 3T (e.g., liver pro-
tocol 9b at 1.5T was more repeatable than liver protocol
4b at 3T ( adjusted P< 104), and prostate protocol 9c at
1.5T was more repeatable than prostate protocol 4c at
3T (adjusted P¼0.0022)), with one exception: Breast
protocol 8 at 3T was more repeatable than breast proto-
col 10 at 1.5 T (adjusted P< 104).
Unlike the VFA approach, the Look-Locker IR method
did not show significantly different repeatability
between protocols at different field strengths (e.g., proto-
cols 4a and 9a for the liver did not have significantly dif-
ferent repeatability). Look-Locker IR protocols 4a (at 3T)
and 9a (at 1.5 T) for the liver were significantly (adjusted
P< 104) more repeatable than the VFA protocol 4b for
the liver at 3T. The superior repeatability of Look-Locker
IR protocols versus VFA is also apparent from the com-
parison of precision errors between the methods. Look-
Locker IR had significantly higher test-retest repeatability
(precision error: 0.6864.64%) than VFA (precision error:
14.76 2.04%, P¼ 0.038) and PD (precision error:
19.86 5.49%, P¼ 0.049), and borderline significantly
higher repeatability than VTR (15.986 4.34%, P¼ 0.088).
There were no significant differences in repeatability
among the other methods (P range 0.8–0.99).
Interplatform Reproducibility
Excellent agreement was found in T1 measurements
between platforms, for both the IR-SE (1.5T: ICC¼ 0.997,
P< 106; 3T: ICC¼ 0.999, P< 106) and VFA (1.5T:
ICC¼ 0.993, P< 106; 3T: ICC¼ 0.947, P< 106) common
protocols. Interplatform CVs of common IR-SE and VFA
T1 values for 1.5T (two scanners) and 3T (eight scan-
ners) are displayed in Table 4 and Figure 6. Interplat-
form reproducibility was higher at 1.5T (root mean
square (RMS) CV 11.13%, range: 0.1–18.8%) than at 3T
(RMS CV 22.87%, range: 16.6–45.5%) for the common
VFA protocol (P¼ 0.004; Table 4). For the common IR-SE
protocol, there was no significant difference in reproduc-
ibility at different field strengths (1.5T: RMS CV 8.21%,
range: 0.11–23%; 3T: RMS CV 5.46%, range 0.99–14.6%;
P¼ 0.379) (Table 4 and Fig. 6). As expected, at both field
strengths the overall reproducibility was higher for the
common IR-SE protocol (P¼ 0.028) than for the common
VFA protocol (P¼ 0.001). Interplatform CV was less than
10% for the IR-SE sequence for most phantom samples,
with the exception of samples with reference NMR T1s
of 33, 45, and 500 ms (Fig. 6).
DISCUSSION AND CONCLUSIONS
Accurate, repeatable, and reproducible quantification of
baseline-tissue T1 is highly desired for patient-specific,
FIG. 6. Interplatform CVs at 1.5 T
(top) and 3 T (bottom) for each
sample with known NMR T1.
Interplatform CV was less than
10% for the IR-SE sequence for
all phantom samples, with the
exception of the ones with refer-
ence NMR T1 values of 33 ms at
1.5 T, 45 ms at 3 T, and approxi-
mately 500 ms at both field
strengths, as a result of fit under-
performance at these values.
Table 4
Interplatform Reproducibility of T1 Measurements Expressed as
CV (%) Using Common IR-SE and VFA Protocols for Reference T1
Values (22.9–2033 ms at 1.5 T; 21.7–1989 ms at 3 T) in the Phan-
tom Solution Samples
RMS CV (%)
Field strength IR-SE VFA
1.5 T 8.21a 11.13b
3 T 5.46c 22.87
Note: Results are summarized as the RMS of within-sample CVs
of the IR-SE and VFA measurements at each field strength. P val-
ues are given for paired-sample Wilcoxon signed-rank tests used
to compare the CV values. IR-SE 1.5 T versus 3 T: P¼0.379.
a1.5 T: IR-SE versus VFA, P¼0.028.
bVFA 1.5 T versus 3 T, P¼0.004.
c3 T: IR-SE versus VFA, P¼0.001.
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robust perfusion quantification from DCE-MRI studies.
The present study expands the scope of previous multi-
center studies of the variability of quantitative MR relax-
ometry metrics (31,32,46). In addition to investigating
sources of error with the same T1 mapping protocols
across scanner platforms, our study also compared the
performance of 14 site-specific T1 mapping protocols
used for different oncological applications. Our study
performed a centralized analysis of site data, to control
for sources of error such as the data-fitting method and
software packages used for analysis. In particular, differ-
ent results may have been obtained for the VFA proto-
cols by fitting the VFA data with the linearized version
of the signal equation, rather than the full signal equa-
tion. The knowledge gained on the magnitude of accu-
racy and repeatability errors, as well as of interplatform
variability of T1 measurements, obtained with different
protocols potentially allows future studies on the propa-
gation of T1 measurement errors to pharmacokinetic
parameters obtained from DCE-MRI studies. Our work
showed the field strength and scanner dependence of
accuracy and test-retest repeatability of T1 measure-
ments. We observed significantly lower interplatform
reproducibility at 3T compared with 1.5T for the com-
mon VFA protocol, and significantly lower reproducibil-
ity of the common VFA protocol compared with the IR-
SE protocol at both field strengths.
Our study also confirmed the expected high accuracy,
repeatability, and interplatform reproducibility of T1
measurements with a common IR-SE protocol. However,
because of the small number of 1.5T systems, the repro-
ducibility findings for both common protocols would
need to be validated with a larger 1.5T scanner pool. For
site-specific T1 quantification protocols for different
DCE-MRI applications, accuracy and repeatability of
measurements were influenced primarily by the type of
protocol and by scanner. Our study identified several
VFA and Look-Locker IR protocols that achieved clini-
cally acceptable accuracy and repeatability errors of less
than 15%.
We observed high concordance between IR-SE and the
reference NMR T1 values, with deviations from unity
line at the solution samples with 500 ms and higher T1
values (1500–2000 ms). Bland-Altman plots showed dis-
crepancy between IR-SE and reference NMR T1 values at
low T1 values (< 50 ms) and 500 ms, but not at high T1
values. Greater interplatform CV was also observed for
the IR-SE sequence at 500 ms at both field strengths. The
deviation from the reference standard in samples with
high T1 values can be explained by not fully recovered
longitudinal magnetization (22,46) at the relatively short
TR (5000 ms) chosen for manageable scanning time. The
variability of IR-SE T1 measurements of the 500-ms sam-
ple is caused by underperformance of the fitting function
with magnitude IR-SE signal data, which can be rem-
edied in future studies by fitting complex signal data
(22,46).
Our findings show that the common IR-SE protocol
had the highest accuracy in the range of 60 to 2000 ms
(accuracy error< 11%). Thus, for applications in which
accuracy is important and longer acquisition times are
possible without motion artifacts, an IR-SE protocol can
be used as calibration for a faster T1 measurement proto-
col (22). Accuracy with the common IR-SE protocol was
also shown to depend on the NiCl2 solution T1, with
lower accuracy for samples with very low reference T1
(23–50 ms). These samples also showed interplatform
CV greater than 10%. Our implemented IR-SE protocol
had up to two measurements with short inversion times
(24–50ms), which makes it difficult to resolve low T1.
Inversion-recovery methods (IR-SE, Look-Locker modi-
fied IR) provided repeatable and reproducible T1 mea-
surement. Lower interplatform CV was observed for the
common IR-SE protocol compared with the VFA com-
mon protocol. The IR-SE precision error was less than
5% for most platforms, and a significantly lower test-
retest precision error/higher repeatability was observed
for the Look-Locker IR than for the VFA and PD methods
in the comparison by general linear model. These results
are in agreement with the work of Stikov et al (22),
which found greater stability of T1 measurements in
vitro and in white matter with Look-Locker IR than with
VFA. Of note, the observed dependence of repeatability
of the common IR-SE protocol on the scanner platform
was likely driven by outlier test-retest precision errors at
one of the scanners. This could be caused by periodic
signal variation on the outlier scanner, as observed in
other studies (46). In our study, the Look-Locker IR pro-
tocol optimized for the liver did not have greater accu-
racy than VFA protocols for the liver, but had greater
test-retest repeatability. Because superior repeatability
with the Look-Locker IR method was observed on only
two platforms (1.5 and 3T) from the same vendor, this
finding should be confirmed in a future multiplatform,
multivendor study.
For T1 measurements with the common VFA protocol,
we observed field strength dependence of accuracy and
scanner dependence of test-retest repeatability, as well
as significantly higher interplatform variability at 3T.
The deviations from the reference NMR measurements
seen with the common VFA and site-specific protocols
(as high as 30–40%) cannot be attributed only to differ-
ences in temperature (accounting for less than 2% error
in T1 for the recorded temperature range (32)). These are
likely caused by B1 field inhomogeneity, which is more
pronounced at 3T compared with 1.5T (8,22), and leads
to variability in T1 values among scanners, even for a
common VFA protocol with the same prescribed flip
angles. Vendor was also a significant predictor of repeat-
ability of T1 measurements with the common VFA proto-
col, which suggests differences in implementation across
vendors. Although the participating sites did their best
to implement a uniform VFA protocol, the B1 pulse pro-
files were unknown and could vary among scanners and
vendors and change across the range of flip angles (32).
Future implementation of a standardized VFA protocol
would involve outreach to vendors to ensure that the B1
correction methods used are appropriate for the pulse
profiles used by the vendors in their implementations of
VFA sequences. Accounting for incomplete spoiling of
the spoiled gradient-echo signal and using the vendor-
specific radiofrequency phase-difference increment can
further be used to eliminate T2 bias in T1 quantification
(33). Our results with the common VFA protocol can
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help facilitate the effort of optimizing VFA protocols
(47,48) by identifying combinations of flip angles that
minimize accuracy error with respect to the reference
NMR-measured T1 values.
Our study showed that although the VTR protocol and
VFA protocols with fewer flip angles were more accurate
(accuracy error< 5%) than a VFA protocol with multiple
flip angles (e.g., VTR prostate protocol 1, and prostate
VFA protocols 9c and 9d versus protocol 2 for the brain),
these protocols were significantly less repeatable (preci-
sion errors of 20–40%). For clinical applications in
which both accuracy and repeatability are important, we
would recommend protocols with accuracy and repeat-
ability errors of less than 15%, such as the Look-Locker
protocol 4a for the liver, VFA protocol 9b for the liver,
or VFA protocol 9d for the prostate at 1.5T.
Our study had some limitations. First, we did not col-
lect complex signal data for any of the T1 mapping meth-
ods, to simulate the clinical setting, in which only
magnitude data are typically collected. Second, we did
not perform B1 mapping to measure the applied flip
angles for the VFA measurements. B1 mapping methods
(49–53) are usually time-consuming, not standardized
among platforms and vendors, and may be specific
absorption rate–prohibitive (51), which limits their clini-
cal applicability. Furthermore, B1 may not be accurately
measured as a result of B0 inhomogeneities and tissue
conductivity (22,54). Third, because participation in the
study was determined by voluntary response to a survey,
the study design was not statistically balanced for field
strength (two 1.5T scanners versus eight 3T scanners)
and vendors (six Siemens scanners, two GE scanners,
two Phillips scanners), which may explain why vendor
was one of the significant predictors of repeatability, but
not of accuracy. The number of site-specific protocols
was also not balanced between sites. Fourth, the effects
of small variations in phantom positioning away from
isocenter were not studied.
In conclusion, our findings show that accuracy, repeat-
ability, and interplatform reproducibility of T1 measure-
ments depend on the T1 measurement sequence and
protocol used, the field strength, and the range of refer-
ence T1 values. Among the site-specific protocols tested,
VFA protocols with two to three flip angles optimized
for different applications achieved an acceptable balance
of accuracy and repeatability in T1 quantification
(errors< 15%). The VFA protocols with two to three flip
angles may be of interest to investigators designing trans-
lational DCE-MRI studies, as they have the advantage of
higher spatial coverage achieved in the acquisition time
of one breath-hold. Further optimization in terms of flip-
angle choice for each tissue application, and the use of
B1 correction standardized among vendors, is needed to
improve the robustness of VFA protocols for T1 mapping
in DCE-MRI for the purpose of multicenter studies.
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Fig. S1. Sample fitting the IR-SE signal in phantom sample S5, with NMR
T1 approximately 500 ms. When fitting Equation [1] to the magnitude signal
data with a Levenberg-Marquardt algorithm with constraints on parameters
T15 [0, Inf], M05 [0, Inf], invF5 [0,2] and noise5 [0, Inf], the fit (in black)
underperforms and T1 is underestimated (T15 370.66 73.6 ms). When
parameters are fitted without constraints, the fit to the data is improved
(red) (T15509.760.91 ms).
Fig. S2. Typical model fit for the IR-SE signal obtained with the common
IR-SE protocol on scanner 4 (3 T) in phantom samples S1 to S14.
Fig. S3. Typical model fit for the VFA signal obtained with the common VFA
protocol on scanner 4 (3 T) in phantom samples S1 to S14.
Table S1. Acquisition Parameters for the Site-Specific T1 Measurement
Protocols at 3 T
Table S2. Acquisition Parameters for the Site-Specific T1 Measurement
Protocols at 1.5 T
Table S3. T1 (ms) Values From NMR Spectroscopy Measurements Per-
formed at NIST at 1.5 and 3 T Used as the Reference Standard
Table S4. Accuracy Error (%) for Each Scanner, With the Common IR-SE
and VFA Protocols, for Ranges of Reference T1 Values in the Phantom
Solution Samples
Table S5. Precision Error (%) for Each Scanner, With the Common IR-SE
and VFA Protocols, for Ranges of Reference T1 Values in the Phantom
Solution Samples
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